These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 8098674)

  • 1. Defect of interleukin-2 production and T cell proliferation in atopic patients: restoring ability of the CD28-mediated activation pathway.
    Romano MF; Turco MC; Stanziola A; Giarrusso PC; Petrella A; Tassone P; van Lier R; Venuta S; Formisano S
    Cell Immunol; 1993 May; 148(2):455-63. PubMed ID: 8098674
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Activation of cord T lymphocytes. III. Role of LFA-1/ICAM-1 and CD2/LFA-3 adhesion molecules in CD3-induced proliferative response.
    Gerli R; Agea E; Muscat C; Tognellini R; Fiorucci G; Spinozzi F; Cernetti C; Bertotto A
    Cell Immunol; 1993 Apr; 148(1):32-47. PubMed ID: 7684326
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Regulation of T-cell differentiation by CD2 and CD28 accessory molecules.
    de Jong R; Stokkers P; Lamme E; Kool JM; Borst F; Brouwer M; Miedema F; van Lier RA
    Immunology; 1991 Oct; 74(2):175-82. PubMed ID: 1684171
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impaired interleukin-2 synthesis and T cell proliferation following antibody-mediated CD3 and CD2 or CD28 cross-linking in trans: evidence that T cell activation requires the engagement of costimulatory molecules within the immunological synapse.
    Watson CL; Furlong SJ; Hoskin DW
    Immunol Invest; 2008; 37(1):63-78. PubMed ID: 18214800
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Activation of cord T lymphocytes. I. Evidence for a defective T cell mitogenesis induced through the CD2 molecule.
    Gerli R; Bertotto A; Crupi S; Arcangeli C; Marinelli I; Spinozzi F; Cernetti C; Angelella P; Rambotti P
    J Immunol; 1989 Apr; 142(8):2583-9. PubMed ID: 2564856
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Selective loss of T cell functions in different stages of HIV infection. Early loss of anti-CD3-induced T cell proliferation followed by decreased anti-CD3-induced cytotoxic T lymphocyte generation in AIDS-related complex and AIDS.
    Gruters RA; Terpstra FG; De Jong R; Van Noesel CJ; Van Lier RA; Miedema F
    Eur J Immunol; 1990 May; 20(5):1039-44. PubMed ID: 2162775
    [TBL] [Abstract][Full Text] [Related]  

  • 7. "CD3low" human thymocyte populations can readily be triggered via the CD2 and/or CD28 activation pathways whereas the CD3 pathway remains nonfunctional.
    Pierres A; Cerdan C; Lopez M; Mawas C; Olive D
    J Immunol; 1990 Feb; 144(4):1202-7. PubMed ID: 1968076
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prolonged IL-2 receptor alpha/CD25 expression after T cell activation via the adhesion molecules CD2 and CD28. Demonstration of combined transcriptional and post-transcriptional regulation.
    Cerdan C; Martin Y; Courcoul M; Brailly H; Mawas C; Birg F; Olive D
    J Immunol; 1992 Oct; 149(7):2255-61. PubMed ID: 1356123
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Signals involved in T cell activation. T cell proliferation induced through the synergistic action of anti-CD28 and anti-CD2 monoclonal antibodies.
    Van Lier RA; Brouwer M; Aarden LA
    Eur J Immunol; 1988 Jan; 18(1):167-72. PubMed ID: 3126073
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interleukin-7 is a potent co-stimulus of the adhesion pathway involving CD2 and CD28 molecules.
    Costello R; Brailly H; Mallet F; Mawas C; Olive D
    Immunology; 1993 Nov; 80(3):451-7. PubMed ID: 7904590
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CD44 contributes to T cell activation.
    Huet S; Groux H; Caillou B; Valentin H; Prieur AM; Bernard A
    J Immunol; 1989 Aug; 143(3):798-801. PubMed ID: 2568380
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Basis for defective proliferation of peripheral blood T cells to anti-CD2 antibodies in primary Sjögren's syndrome.
    Gerli R; Bertotto A; Agea E; Lanfrancone L; Cernetti C; Spinozzi F; Rambotti P
    J Clin Invest; 1990 Dec; 86(6):1870-7. PubMed ID: 1979333
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ex vivo expansion of dendritic-cell-activated antigen-specific CD4+ T cells with anti-CD3/CD28, interleukin-7, and interleukin-15: potential for adoptive T cell immunotherapy.
    Chen HW; Liao CH; Ying C; Chang CJ; Lin CM
    Clin Immunol; 2006 Apr; 119(1):21-31. PubMed ID: 16406844
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Crosslinking of CD27 in the presence of CD28 costimulation results in T cell proliferation and cytokine production.
    Sunder-Plassmann R; Pickl WF; Majdic O; Knapp W; Holter W
    Cell Immunol; 1995 Aug; 164(1):20-7. PubMed ID: 7634349
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Adenosine inhibits activation-induced T cell expression of CD2 and CD28 co-stimulatory molecules: role of interleukin-2 and cyclic AMP signaling pathways.
    Butler JJ; Mader JS; Watson CL; Zhang H; Blay J; Hoskin DW
    J Cell Biochem; 2003 Aug; 89(5):975-91. PubMed ID: 12874832
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evidences for protein kinase C. Activation in T lymphocytes by stimulation of either the CD2 or CD3 antigens.
    Friedrich B; Cantrell DA; Gullberg M
    Eur J Immunol; 1989 Jan; 19(1):17-23. PubMed ID: 2563972
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CD28-mediated activation of resting human T cells without costimulation of the CD3/TCR complex.
    Siefken R; Kurrle R; Schwinzer R
    Cell Immunol; 1997 Feb; 176(1):59-65. PubMed ID: 9070318
    [TBL] [Abstract][Full Text] [Related]  

  • 18. T-cell activation by recombinant receptors: CD28 costimulation is required for interleukin 2 secretion and receptor-mediated T-cell proliferation but does not affect receptor-mediated target cell lysis.
    Hombach A; Sent D; Schneider C; Heuser C; Koch D; Pohl C; Seliger B; Abken H
    Cancer Res; 2001 Mar; 61(5):1976-82. PubMed ID: 11280755
    [TBL] [Abstract][Full Text] [Related]  

  • 19. T cells of patients with the Wiskott-Aldrich syndrome have a restricted defect in proliferative responses.
    Molina IJ; Sancho J; Terhorst C; Rosen FS; Remold-O'Donnell E
    J Immunol; 1993 Oct; 151(8):4383-90. PubMed ID: 8409409
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Regulation of interleukin-4 production in human mononuclear cells.
    Holter W; Majdic O; Kalthoff FS; Knapp W
    Eur J Immunol; 1992 Oct; 22(10):2765-7. PubMed ID: 1356786
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.